NOMIX utilizes autonomous AI agents and blockchain technology to analyze personal omics and biomarker data, generating tailored longevity recommendations for users. This approach addresses the challenge of optimizing individual healthspan by providing data-driven insights and secure management of health information.
Funding
Funding not disclosed
Founders
Product
Problem
Individuals seeking to optimize their healthspan face the challenge of interpreting complex personal omics and biomarker data. The lack of personalized, data-driven insights and secure management of sensitive health information hinders effective longevity planning.
Solution
NOMIX AI leverages autonomous AI agents and blockchain technology to analyze personal omics and biomarker data, providing users with tailored longevity recommendations. The platform uses individual personal omics and biomarker data to train AI Agent algorithms, creating longevity recommendations and developing predictive, proactive, personalized medicine. Users receive NOMIX OM and digital token rewards within the BIOCOACH app for providing their biodata. The BIOCOACH app also facilitates communication with a personal BIOCOACH and the Autonomous AI Agent, guiding users toward a longer and healthier life.
Target Audience
The primary target audience includes individuals interested in longevity, personalized health, and optimizing their healthspan through data-driven insights, as well as healthcare professionals and researchers.
Features
- Autonomous AI Agents that answer health- and longevity-related questions
- Secure management of individual biodata using Web3 technologies
- BIOCOACH app for receiving NOMIX OM rewards and communicating with personal BIOCOACH
- Personalized AI-based longevity recommendations
- Privacy-preserving data management
- Integration of personal omics and biomarker data for training AI algorithms
- NOMIX Token rewards for user participation